For Media: UK Press Releases

This page contains resources intended for journalists only. For media enquiries about our press releases please contact ukmediaenquiries@bayer.com

News context

News Area (field_news_area)

News Topic (field_news_topic)

Country

November 01, 2023

Bayer UKI launches first digital patient support package in diabetic kidney disease

October 10, 2023

Bayer invests 250 million USD in new cell therapy manufacturing facility in the U.S.

October 09, 2023

Scottish Medicines Consortium (SMC) recommends two Bayer cancer treatments for use within NHSScotland

May 19, 2023

NICE recommends Bayer’s NUBEQA®▼ (darolutamide) + ADT in combination with docetaxel

March 23, 2023

NICE publishes guidance recommending Bayer’s Kerendia®▼(finerenone)

February 10, 2023

NICE gives green light for Stivarga® (regorafenib) in metastatic colorectal cancer (mCRC)

December 15, 2022

Bayer receives acceptance of Kerendia®▼ (finerenone) by Scottish Medicines Consortium (SMC)

November 28, 2022

NUBEQA®▼ (darolutamide) + ADT in combination with docetaxel licenced by MHRA